Evidence map›Paper›PMID 37435868›Full record

ArticleBirth defects research2023

Ezh2-dependent methylation in oral epithelia promotes secondary palatogenesis.

Bo Sun, Kurt Reynolds, Subbroto Kumar Saha, Shuwen Zhang, Moira McMahon, Chengji J Zhou

Open access · bronzeAbstract read
In one paragraph

Article in Birth defects research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 83% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Bo SunInstitute for Pediatric Regenerative Medicine of Shriners Hospital for Children-Northern California & Department of Biochemistry and Molecular Medicine, School of Medicine, University of California at Davis, Sacramento, California, USA.
Kurt ReynoldsInstitute for Pediatric Regenerative Medicine of Shriners Hospital for Children-Northern California & Department of Biochemistry and Molecular Medicine, School of Medicine, University of California at Davis, Sacramento, California, USA.ORCID 0000-0003-3315-8157
Subbroto Kumar SahaInstitute for Pediatric Regenerative Medicine of Shriners Hospital for Children-Northern California & Department of Biochemistry and Molecular Medicine, School of Medicine, University of California at Davis, Sacramento, California, USA.
Shuwen ZhangInstitute for Pediatric Regenerative Medicine of Shriners Hospital for Children-Northern California & Department of Biochemistry and Molecular Medicine, School of Medicine, University of California at Davis, Sacramento, California, USA.
Moira McMahonInstitute for Pediatric Regenerative Medicine of Shriners Hospital for Children-Northern California & Department of Biochemistry and Molecular Medicine, School of Medicine, University of California at Davis, Sacramento, California, USA.
Chengji J ZhouInstitute for Pediatric Regenerative Medicine of Shriners Hospital for Children-Northern California & Department of Biochemistry and Molecular Medicine, School of Medicine, University of California at Davis, Sacramento, California, USA.ORCID 0000-0001-8592-4680
Shriners Hospitals for Children - Erie · US

Funding

Cellular and molecular mechanisms of orofacial cleftsR01DE026737 · NIDCR · UNIVERSITY OF CALIFORNIA AT DAVIS · PI ZHOU, CHENGJI · 2017 to 2021
$3.1M
Surface ectodermal mechanism and maternal intervention of neural tube defectsR01NS102261 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI ZHOU, CHENGJI · 2018 to 2022
$2.5M
NIDCR NIH HHS R01 DE026737NINDS NIH HHS R01 NS102261
6 · The paper itself

Abstract

backgroundIn addition to genomic risk variants and environmental influences, increasing evidence suggests epigenetic modifications are important for orofacial development and their alterations can contribute to orofacial clefts. Ezh2 encodes a core catalytic component of the Polycomb repressive complex responsible for addition of methyl marks to Histone H3 as a mechanism of repressing target genes. The role of Ezh2 in orofacial clefts remains unknown.

aimsTo investigate the epithelial role of Ezh2-dependent methylation in secondary palatogenesis.

methodsWe used conditional gene-targeting methods to ablate Ezh2 in the surface ectoderm-derived oral epithelium of mouse embryos. We then performed single-cell RNA sequencing combined with immunofluorescence and RT-qPCR to investigate gene expression in conditional mutant palate. We also employed double knockout analyses of Ezh1 and Ezh2 to address if they have synergistic roles in palatogenesis.

resultsWe found that conditional inactivation of Ezh2 in oral epithelia results in partially penetrant cleft palate. Double knockout analyses revealed that another family member Ezh1 is dispensable in orofacial development, and it does not have synergistic roles with Ezh2 in palatogenesis. Histochemistry and single-cell RNA-seq analyses revealed dysregulation of cell cycle regulators in the palatal epithelia of Ezh2 mutant mouse embryos disrupts palatogenesis.

conclusionEzh2-dependent histone H3K27 methylation represses expression of cell cycle regulator Cdkn1a and promotes proliferation in the epithelium of the developing palatal shelves. Loss of this regulation may perturb movement of the palatal shelves, causing a delay in palate elevation which may result in failure of the secondary palate to close altogether.

Indexed as

Cleft LipCleft PalateAnimalsEnhancer of Zeste Homolog 2 ProteinHistonesMethylationMicePolycomb-Group ProteinsEnhancer of Zeste Homolog 2 ProteinEzh2 protein, mouseHistonesPolycomb-Group Proteinscleft palateEzh2H3K27me3methylationorofacial epitheliaproliferationscRNA-seq

Identifiers

PMID37435868
PMCPMC10784412
OpenAlexW4383999374

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.